Investments – Page 10

Ajax Pharmaceuticals Secures $95 Million for JAK Inhibitor Drug Development

1 year ago talkbio0Tagged Autoimmune Diseases, Drug Development, Inflammatory disorder, inhibitors, Investments, Janus kinase

Ajax Pharmaceuticals, JAK inhibitors, drug development, funding, investment, inflammatory diseases, autoimmune disorders, cancer.

Sanofi Invests $500M in Novavax’s Covid Vaccine, Exploring Commercialization and Flu Combination

1 year ago talkbio0Tagged Combined, commercialization, Covid Vaccine, Investments, Novavax, sanofi

Sanofi, Novavax, Covid vaccine, commercialization, flu combination, $500M investment

Royalty Pharma Invests $525 Million in Sanofi-Licensed Multiple Sclerosis Therapy Royalties and Milestones

1 year ago talkbio0Tagged Health care facility, Investments, milestones, multiple sclerosis therapy, Pharma, royalties, Royalty, sanofi

Royalty Pharma, Sanofi, multiple sclerosis therapy, royalties, milestones, investment, healthcare, pharmaceuticals, licensing

Prologue Ventures: Revolutionizing Viral Protein Drug Development with $50 Million Investment

1 year ago talkbio0Tagged Biotechnology, Drug Development, healthcare innovation, Investments, Prologue Ventures, Viral Proteins

Prologue Ventures, viral protein drugs, $50 million investment, drug development, biotechnology, healthcare innovation.

Chiesi Invests Heavily in Gossamer’s Promising Pulmonary Hypertension Treatment

1 year ago talkbio0Tagged Cardiovascular Diseases, Chiesi, Clinical Trials, Collaboration, Drug Development, GD-001, Gossamer, Investments, Pulmonary Hypertension

Chiesi, Gossamer, pulmonary hypertension, drug development, investment, collaboration, GD-001, clinical trials, cardiovascular diseases.

AstraZeneca Strengthens Partnership with Cellectis in Cell and Gene Therapy Advancement

1 year ago talkbio0Tagged AstraZeneca, Biotechnology, Cell Therapy, Cellectis, development aspects, Discover, gene therapy, Health care facility, innovation, Investments, Medical Research activity, Papillary thyroid carcinoma, Partnership, stake

AstraZeneca, Cellectis, cell therapy, gene therapy, partnership, stake, discovery, pact, biotechnology, healthcare, investment, innovation, medical research, therapeutic development.

Novo Holdings Supports Reunion Neuroscience’s $103M Series A Funding for Pioneering Psychedelic Clinical Trials

1 year ago talkbio0Tagged Biotechnology, Funding, Health care facility, Holdings, Investments, mental health, mental health innovation, Neuroscience discipline, psychedelic clinical trials, Reunion Island, Series, venture

Novo Holdings, Reunion Neuroscience, Series A funding, psychedelic clinical trials, mental health treatments, mental health innovation, venture capital, biotechnology, healthcare investments.